1. Home
  2. |Insights
  3. |Fair Pay and Safe Workplaces, We Hardly Knew Ye

Fair Pay and Safe Workplaces, We Hardly Knew Ye

Client Alert | less than 1 min read | 03.28.17

On March 27, 2017, President Trump signed a joint resolution under the Congressional Review Act disapproving the Fair Pay and Safe Workplaces Final Rule. Most of the rule’s requirements were put on hold in October when a U.S. district court judge in Texas granted a preliminary injunction (discussion available here); however, the rule’s paycheck transparency requirements became effective on January 1, 2017. The President’s signature will eliminate the entire rule, including the paycheck transparency requirements, relieving contractors of substantial compliance burdens associated with the FAR rules and Department of Labor Guidance implementing the EO.

Contacts

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights